Clinical Trial Update: A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating how insulin NNC0471-0119 H behaves in the body when delivered via an insulin pump in people with Type 2 diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin NNC0471-0119 H

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED